As I Read the op-ed piece “Does a Drug Firm's Free Lunch Influence Doctors?” (Boston Globe, May 18), I thought, how unusual — this writer actually seems to have a positive attitude about pharmaceutical industry/physician relationships. The piece was responding to the survey of those interactions published recently in The New England Journal of Medicine. Then I saw the byline — Scott Lassman, senior assistant general counsel for the Pharmaceutical Research and Manufacturers of America. Aha. ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.